KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to $97.9 million.

  • Neogenomics' Total Current Liabilities fell 66.98% to $97.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.9 million, marking a year-over-year decrease of 66.98%. This contributed to the annual value of $301.2 million for FY2024, which is 212.80% up from last year.
  • As of Q3 2025, Neogenomics' Total Current Liabilities stood at $97.9 million, which was down 2.25% from $100.1 million recorded in Q2 2025.
  • Neogenomics' Total Current Liabilities' 5-year high stood at $301.2 million during Q4 2024, with a 5-year trough of $67.8 million in Q1 2021.
  • For the 3-year period, Neogenomics' Total Current Liabilities averaged around $164.8 million, with its median value being $97.9 million (2025).
  • The largest annual percentage gain for Neogenomics' Total Current Liabilities in the last 5 years was 264.61% (2025), contrasted with its biggest fall of 66.98% (2025).
  • Neogenomics' Total Current Liabilities (Quarterly) stood at $87.2 million in 2021, then rose by 3.10% to $89.9 million in 2022, then rose by 7.09% to $96.3 million in 2023, then skyrocketed by 212.80% to $301.2 million in 2024, then tumbled by 66.98% to $97.9 million in 2025.
  • Its Total Current Liabilities stands at $97.9 million for Q3 2025, versus $100.1 million for Q2 2025 and $279.7 million for Q1 2025.